Grant: Discovery Grants Program - Individual
McGill University
$32,000.00
Devices and procedures to quantify radiation quality effects in radiotherapy
EF 2013-14
Résumé
The goal of radiation therapy is to use radiation to damage tumor cells to an extent that they are either dead (necrotic), or not viable to reproduce (sterile). To control the amount of radiation delivered to the patient, several physical or biological quantities have been suggested and are routinely in use. Although perhaps the most relevant quantity in radiotherapy would be a measure of cell death, the current accepted quantity is physical absorbed dose to water (energy deposited per unit mass of water).Recent novel developments in radiotherapy have resulted in complex delivery systems and radiation treatment plans. At times, the complexity is such that our currently accepted dosimetric protocols and detectors prove insufficient in accurately determining the absorbed dose. Moreover, current evidence-based clinical practice in radiotherapy does not take into consideration the details of radiobiological effects on individual patient treatment plan. The goal of this project is to improve the radiation dosimetry for novel delivery methods and to eventually develop a radiotherapy treatment planning solution that is commissioned and operated based on radiobiological effectiveness of the radiation beam. As such, radiotherapy treatments will be optimized to achieve a certain distribution of cell damage based on tumour type/grade/location and normal tissue proximity. We are developing an absolute dose meter that is superior in characteristics to many of contemporary detectors. Moreover, we suggest a novel approach to measurement of radiation beam quality that indirectly relates to cell damage and paves the way towards a biological effectiveness-based treatment planning software. We will be studying the effects of various modern delivery techniques including particle therapy on radiation dosimetry and biological cell tissue damage.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
435608-2013
Name nom
Sarfehnia, Arman
Department département
Oncology
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
32000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3114
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biological and Medical Physics
Research subject fr
Physique biologique et médicale
Partie
1
Nb partie
5
Application title
Devices and procedures to quantify radiation quality effects in radiotherapy
Keyword
NSERC
Application summary
The goal of radiation therapy is to use radiation to damage tumor cells to an extent that they are either dead (necrotic), or not viable to reproduce (sterile). To control the amount of radiation delivered to the patient, several physical or biological quantities have been suggested and are routinely in use. Although perhaps the most relevant quantity in radiotherapy would be a measure of cell death, the current accepted quantity is physical absorbed dose to water (energy deposited per unit mass of water).Recent novel developments in radiotherapy have resulted in complex delivery systems and radiation treatment plans. At times, the complexity is such that our currently accepted dosimetric protocols and detectors prove insufficient in accurately determining the absorbed dose. Moreover, current evidence-based clinical practice in radiotherapy does not take into consideration the details of radiobiological effects on individual patient treatment plan. The goal of this project is to improve the radiation dosimetry for novel delivery methods and to eventually develop a radiotherapy treatment planning solution that is commissioned and operated based on radiobiological effectiveness of the radiation beam. As such, radiotherapy treatments will be optimized to achieve a certain distribution of cell damage based on tumour type/grade/location and normal tissue proximity. We are developing an absolute dose meter that is superior in characteristics to many of contemporary detectors. Moreover, we suggest a novel approach to measurement of radiation beam quality that indirectly relates to cell damage and paves the way towards a biological effectiveness-based treatment planning software. We will be studying the effects of various modern delivery techniques including particle therapy on radiation dosimetry and biological cell tissue damage.